Article

Study compares visual outcomes with femtosecond, mechanical microkeratomes

Washington, DC &#8212 Initial results from a prospective, parallel group comparison trial slightly favor use of the femtosecond microkeratome (IntraLase) compared with two mechanical microkeratomes for performing wavefront-guided LASIK.However, they point to no benefits when performing the procedures using a staged approach that takes into account the potential for flap creation to affect higher order aberrations compared with standard immediate ablation, reported David Tanzer, MD, at the American Society of Cataract and Refractive Surgery meeting.

April 17 - Washington, DC - Initial results from a prospective, parallel group comparison trial slightly favor use of the femtosecond microkeratome (IntraLase) compared with two mechanical microkeratomes for performing wavefront-guided LASIK.

However, they point to no benefits when performing the procedures using a staged approach that takes into account the potential for flap creation to affect higher-order aberrations compared with standard immediate ablation, reported David Tanzer, MD, at the American Society of Cataract and Refractive Surgery meeting.

The study is being conducted at the Naval Medical Center, San Diego. Patients underwent wavefront-guided LASIK using the VISX STAR S4 CustomVue (version 3.07) excimer laser after flap creation with the AMO Amadeus, Bausch & Lomb Hansatome, or IntraLase microkeratomes. Fifty patients in each microkeratome arm were randomized to undergo standard treatment with flap creation followed by immediate ablation and another 50 patients received a staged procedure in which the flap was cut, lifted, and laid back down, but the patient returned 4 weeks later for wavefront measurement and laser treatment.

Two surgeons-Dr. Tanzer and Steve Schallhorn, MD-performed all of the surgeries.Early clinical outcomes favored the femtosecond laser group. At 1 day, 1 week, and 1 month, the proportion of patients achieving 20/16 UCVA was significantly higher in patients with femtosecond laser-created flaps compared with the mechanical microkeratome groups. At 3 months, the UCVA and MSE outcomes were similar in all groups, but a significantly higher proportion of patients in the femtosecond laser group gained 1 line of BCVA, and results of mesopic contrast acuity testing also favored the femtosecond laser.

Considering eyes that received a staged procedure, there was a slight reduction in higher-order aberrations after 1 month in the femtosecond group and slight induction in both mechanical microkeratome groups. However, comparisons between standard and staged treatment groups within each microkeratome arm showed no statistically significant benefits for staging the procedure with respect to visual, refractive, or predictability outcomes.

"Currently, Navy aviators can only receive PRK. With consideration being given to the possibility of performing LASIK, this study is being conducted to evaluate the best flap technology for flap creation and whether better outcomes can be achieved with a staged approach that takes into account flap creation-induced higher-order aberrations," Dr. Tanzer said.

"So far, there appear to be some benefits for the femtosecond laser, but not for the staged approach. However, this is the first time this dataset has been reported, the results must be considered preliminary, and we will be analyzing other important endpoints," he concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.